The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
People with stroke due to brain hemorrhage have swelling around the hemorrhage on their brain scan. This programme is about understanding the effect of blood on brain cells, with a focus on finding treatments.
People who have survived a previous stroke or transient ischaemic attack (TIA) are at particularly high risk of subsequent, ‘recurrent’ stroke with 30% having another stroke in the following five years. High blood pressure is the most important reversible risk factor for having a recurrent stroke. The aim of this study is to develop and test a self-monitoring system of high blood pressure, tailored to the needs of stroke and TIA survivors, which will include self-adjustment of medication where possible in consultation with a GP.
This study will investigate whether adult stem cells can be transformed and used to reduce inflammation in the brain after stroke, and promote recovery.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initiation could lead to fewer recurrent strokes.
This study aims to address the need for evidence-based treatments and improve clinical expertise to address problems with everyday conversation after stroke.
The International Stroke Conference is taking place in Los Angeles on 24-26 January 2018). It’s the world’s largest meeting about the science and treatment of stroke.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.
Published online first in the journal Neurology, a new study investigates the effectiveness of tools used to predict the recovery of patients after stroke.